Home » Topics » Defective Medical Devices » AMS Transvaginal Mesh

AMS Transvaginal Mesh Complications, Side Effects Lawsuit

Transvaginal Mesh Complications, Side Effects, Lawsuit | Transvaginal Mesh, Pelvic Mesh, Surgical Mesh, Pelvic Sling | Lawsuits, Lawyer, Attorney | Side Effects: Bleeding, Pelvic Pain, Infection, Surgical Mesh Infection, Vaginal Epithelium Erosion, Erosion of Vaginal Tissue, Mesh Erosion, Pain, Incontinence, Urinary Problems, Prolapse, Bowel Perforation, Bladder Perforation, Blood Vessel Perforation, Pressure or “fullness” in the lower abdomen, Dyspareunia, Painful Sexual Intercourse, Vaginal bleeding Vaginal infections, Vaginal pain not related to intercourse, Vaginal Scarring, Neuropathic Numbness Or Weakness | Impaired Healing, Complications, Revision Surgery For Pelvic Organ Prolapse (POP) or Stress Urinary Incontinence (SUI)

Transvaginal surgical mesh implants or pelvic slings marketed by American Medical Systems (AMS) have been implanted in thousands of women in urogynecologic procedures to repair pelvic organ proplase (POP) and stress urinary incontinence (SUI). Unfortunately, many AMS vaginal mesh devices have been associated with a high rate of complications. Women throughout the country have filed AMS transvaginal or pelvic mesh lawsuits seeking compensation for serious injuries, including erosion and extrusion of mesh, perforation of organs, vaginal bleeding, chronic infection, pain and emotional distress.

AMS transvaginal mesh/sling products that have been the subject of lawsuits and adverse event reports include those sold under the names:

Photo courtesy: emedicine.medscape.com website

• Elevate
• Apogee
• Perigee
• Spare
• Monarch
• Mini-Arc

These AMS transvaginal mesh products are intended to act as a hammock to support prolapsed organs and improve symptoms associated with POP and SUI. In surgical POP repair, AMS transvaginal surgical mesh products are implanted to provide support for the female’s pelvic organs when they drop, fall, bulge or protrude (prolapse) into the vaginal wall due to weakened or stretched muscles that occur from childbirth, pregnancy and other causes. These surgical mesh devices can be implanted to repair prolapse of the bladder (cystocele), top of the vagina (apical prolapse), uterus (procidentia), rectum (rectocele), bowel (enterocele) and urethra.

AMS vaginal mesh/sling products may also be used to repair SUI, which occurs as a result of weakened pelvic muscles that support the bladder and urethra. The condition is most common in women who have had multiple pregnancies and vaginal childbirths, and who suffer from pelvic organ prolapse (POP).

AMS Transvaginal and Pelvic Mesh Adverse Events and Failures

AMS transvaginal mesh and pelvic mesh complications may include:

• Erosion of the mesh through the vaginal tissue
• Exposure or extrusion of mesh, which can require multiple surgeries
• Feeling a lump in the vaginal opening or something protruding from vagina
• Painful sexual intercourse
• Perforation or puncture of the bladder, intestines and bowels, as well as blood vessels around the vaginal wall
• Recurrent Pelvic Organ Prolapse (POP)
• Recurrent Stress Urinary Incontinence (SUI)
• Urinary problems
• Vaginal bleeding
• Vaginal chronic drainage, discharge and infections
• Vaginal pain
• Vaginal scarring and shortening

Women who experience AMS transvaginal mesh and pelvic sling failures often undergo at least one additional surgical procedure to remove the device. However, it is not usual for victims of AMS surgical mesh complications to require repeated excision surgeries. Unfortunately, excision surgery does not guarantee that complications will be reversed, and many women will continue to suffer with vaginal pain and an impaired quality of life.

AMS Transvaginal Mesh and Pelvic Sling Lawsuits

Victims of AMS vaginal mesh implant and sling failures who file a transvaginal mesh lawsuit may be able to collect damages for:

• Additional surgery and multiple surgical revisions
• Emotional distress
• Loss of ability to have sexual relations
• Loss of quality of life
• Lost wages
• Out-of-pocket medical, surgical and hospital expenses
• Pain and Suffering
• Spousal loss of consortium

It is expected that litigation surrounding AMS transvaginal mesh and pelvic sling products will only continue to grow, especially as the U.S. Food & Drug Administration (FDA) continues to scrutinize the safety risks, complications and failures of surgical mesh implanted transvaginally to treat POP and SUI. Lawyers at our firm who specialize in defective medical device are offering free lawsuit evaluations to victims of vaginal surgical mesh implant failures. To learn how you may be able to recover damages for your pelvic mesh injuries, emotional distress, and pain and suffering, we urge you to contact our transvaginal mesh failure lawyers today for your free consultation.

News about AMS Transvaginal Mesh

Recently, lawsuits involving AMS Elevate, Perigee and Apogee vaginal mesh products were consolidated in the Superior Court for the State of Delaware, New Castle before Honorable Mary Johnston.

According to an FDA  safety communication issued on July 13, 2011, 2,874 new reports of complications - 1,503 involving POP repairs and 1,371 invoving SUI repairs - associated with transvaginal surgical mesh procedures were made to the agency from January 2008 through December 2010. Studies reviewed by the FDA also indicated that roughly 10 percent of women who undergo a procedure involving transvaginal placement of surgical mesh will suffer mesh erosion within 12 months of surgery. More than half will need to undergo an additional surgery to remove the mesh, but in many of these cases, the excision procedure will not resolve their mesh failure symptoms. The FDA was unable to find conclusive evidence showing that transvaginally placed mesh in POP repair is more effective than traditional non-mesh repair in all patients with POP and that “it may expose patients to greater risk”.

Public Citizen, the consumer advocacy group founded by Ralph Nader, petitioned the FDA on August 25, 2011 to recall transvaginal mesh products due to safety considerations and their association with painful and debilitating complications.

In an "Executive Summary" released on August 31, 2011, the FDA said it "believes that vaginal placement of surgical mesh for Pelvic Organ Prolapse (POP) repair inherently introduces risks of complications that are unique to the mesh itself."

During a meeting convened in September 2011, a majority of outside experts on the FDA's Obstetrics & Gynecology (OB/GYN) Medical Device advisory panel agreed that the safety, effectiveness and benefit of transvaginal mesh devices in POP repair has not been well established and warrants long term prospective follow-up of patients. The FDA is considering a proposal to reclassify transvaginal mesh devices used in the repair of POP to Class 3 from their current Class 2 designation, thereby making surgical mesh for POP repair ineligible for the FDA’s less-stringent 510(k) approval protocols, and require that such devices be subjected to human clinical trials in order to gain FDA approval for this use.

Legal Help for Victims of AMS Transvaginal Mesh Complications

If you or a loved one suffered painful injuries as a result of POP or SUI repair that involved an AMS vaginal mesh implant or pelvic sling, you may have valuable legal rights. To learn more about obtaining compensation for transvaginal mesh injuries, please fill out our online form, or call 1 800 LAW INFO (1-529-4636) today.